Representation in Clinical Research

Representation matters in clinical trials. When certain populations are underrepresented, the treatments developed may not work as effectively for everyone. Increasing the diversity of participants in clinical trials enables pharmaceutical companies not only to develop treatments that address the needs of diverse populations, but also to enable more equitable healthcare.

Our commitment goes beyond individual studies. We aim to foster trust, engagement, and inclusion across all aspects of clinical research. By working together, we can break down barriers and ensure that every voice is heard in the development of new medicines and deliver better outcomes for patients everywhere.

References